Pharmacist review prevents evolving metformin-associated lactic acidosis

Mark NAUNTON; Greg KYLE; Katja Naunton-Boom

doi:10.1111/jcpt.12187

Pharmacist review prevents evolving metformin-associated lactic acidosis

Mark NAUNTON, Greg KYLE, Katja Naunton-Boom

Pharmacy

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

WHAT IS KNOWN: There is controversy surrounding the risk of metformin and the development of lactic acidosis. There have been no reports of a pharmacist preventing a patient developing metformin-associated lactic acidosis.

Original language	English
Pages (from-to)	567-570
Number of pages	4
Journal	Journal of Clinical Pharmacy and Therapeutics
Volume	39
Issue number	5
DOIs	https://doi.org/10.1111/jcpt.12187
Publication status	Published - 2014

Access to Document

10.1111/jcpt.12187

Fingerprint Dive into the research topics of 'Pharmacist review prevents evolving metformin-associated lactic acidosis'. Together they form a unique fingerprint.

Cite this

@article{4430a8b33d02454baf2b25c8e619c251,

title = "Pharmacist review prevents evolving metformin-associated lactic acidosis",

abstract = "WHAT IS KNOWN: There is controversy surrounding the risk of metformin and the development of lactic acidosis. There have been no reports of a pharmacist preventing a patient developing metformin-associated lactic acidosis.",

author = "Mark NAUNTON and Greg KYLE and Katja Naunton-Boom",

year = "2014",

doi = "10.1111/jcpt.12187",

language = "English",

volume = "39",

pages = "567--570",

journal = "Journal of Clinical and Hospital Pharmacy",

issn = "0269-4727",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Pharmacist review prevents evolving metformin-associated lactic acidosis

AU - NAUNTON, Mark

AU - KYLE, Greg

AU - Naunton-Boom, Katja

PY - 2014

Y1 - 2014

N2 - WHAT IS KNOWN: There is controversy surrounding the risk of metformin and the development of lactic acidosis. There have been no reports of a pharmacist preventing a patient developing metformin-associated lactic acidosis.

AB - WHAT IS KNOWN: There is controversy surrounding the risk of metformin and the development of lactic acidosis. There have been no reports of a pharmacist preventing a patient developing metformin-associated lactic acidosis.

U2 - 10.1111/jcpt.12187

DO - 10.1111/jcpt.12187

M3 - Article

VL - 39

SP - 567

EP - 570

JO - Journal of Clinical and Hospital Pharmacy

JF - Journal of Clinical and Hospital Pharmacy

SN - 0269-4727

IS - 5

ER -